News Powered By:
– a collaborative partner.
CenterWatch News Online Headlines : May 27, 2015 8:38 am : Centerwatch
The Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit organization, has announced the upcoming Medical Heroes Appreciation Walk in Washington D.C. to honor the volunteers who give the gift of participation in clinical research and to raise awareness about the importance of clinical research in advancing public health.
CenterWatch News Online Headlines : May 27, 2015 7:24 am : Centerwatch
Qiagen, a Netherlands-based holding company, has launched its Qiagen Clinical Insight (QCI) bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS). The first two supported applications for the bioinformatics platform are in oncology for somatic and hereditary cancer testing.
The Bayer Group has released a financial update for 2014. The company had strengthened its life science businesses HealthCare and CropScience through acquisitions and decided to demerge the MaterialScience business. Dr. Marijn Dekkers, management board chairman, also listed four strategic priorities for Bayer’s successful further development.
CenterWatch News Online Headlines : May 27, 2015 7:22 am : Centerwatch
AVEO Oncology, a biopharmaceutical company developing targeted therapies through biomarker-driven insights, has relocated its corporate headquarters to Cambridge, Mass.
CenterWatch News Online Headlines : May 27, 2015 7:21 am : Centerwatch
Global CRO Parexel International has launched enhancements to its Randomization and Trial Supply Management (RTSM) service, ClinPhone RTSM. Parexel designed the enhanced service to simplify patient randomization and clinical supply management and to offer greater speed and flexibility in tailoring the service to meet the needs of clinical trials, while reducing delivery timelines. For the improvements, Parexel integrated the interactive response technology acquired from ClinIntel in October 2014 with Parexel’s experience in delivering RTSM services to thousands of studies to create an enhanced fourth-generation technology platform.